Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Frost & Sullivan Institute Recognizes Samsung Biologics with the 2022 Global Enlightened Growth Leadership Award for its Commitment to Sustainable Growth 2022-08-09 21:17
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine 2022-08-01 21:00
Samsung Biologics Reports Second Quarter 2022 Financial Results 2022-07-27 14:43
Samsung Biologics to purchase land for its second Bio Campus 2022-07-18 19:00
'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report 2022-07-11 19:00
Samsung Biologics Reports First Quarter 2022 Financial Results 2022-04-27 14:42
Samsung Biologics completes full acquisition of Samsung Bioepis 2022-04-20 14:45
Samsung Biologics holds 11th Annual General Meeting of Shareholders 2022-03-29 09:42
Samsung Biologics receives 2022 CMO Leadership Award in all six categories 2022-02-07 20:00
Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis 2022-01-28 08:10
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results 2022-01-24 16:25
Samsung Biologics Shares Strategic Roadmap for Sustainable Growth at the 40th Annual JP Morgan Healthcare Conference 2022-01-13 08:52
Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea 2021-12-14 13:34
Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy 2021-12-14 08:55
Samsung Biologics adds to global ISO certifications with Quality Management System 2021-12-07 13:04
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing 2021-11-24 20:00
Samsung Biologics Reports Third Quarter 2021 Financial Results 2021-10-26 15:23
Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA 2021-09-22 18:00
Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative 2021-09-13 12:41
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy 2021-07-20 20:00
1 2 3 4 5